Megan joined Greaves Brewster in 2024 as a chartered UK and European Patent attorney. She entered the patent attorney profession in 2019 with a strong background in biological sciences, having obtained a PhD in Cell and Molecular Biology from the University of Manchester and undertaken research in several different biological sciences labs, including spending a year at the Mayo Clinic, Florida, performing cancer research.
Whilst training and working as a patent attorney, Megan has gained experience in both private practice and in-house settings, most recently spending two years at Oxford-based biotech, Evox Therapeutics. Megan has diverse experience in different aspects of patent practice, including drafting and prosecuting patent applications, managing patent families, EPO opposition proceedings and assessing freedom to operate. When working in-house, she also advised scientific, legal and business development teams on IP matters and helped to develop IP strategies. Megan has worked on a wide variety of different biotechnologies and particularly enjoys work relating to therapeutics, including vaccines, antisense technologies, and gene therapies.
Megan’s solid foundation in biology, coupled with her intellectual property experience and flexible approach, positions her to provide highly effective guidance on IP matters.